CAS: 119514-66-8 - Lifarizine
Fórmula:C29H32N4
InChI:InChI=1/C29H32N4/c1-22-13-15-26(16-14-22)29-30-23(2)27(31-29)21-32-17-19-33(20-18-32)28(24-9-5-3-6-10-24)25-11-7-4-8-12-25/h3-16,28H,17-21H2,1-2H3,(H,30,31)
- Sinónimos:
- 1-(diphenylmethyl)-4-{[5-methyl-2-(4-methylphenyl)-1H-imidazol-4-yl]methyl}piperazine
- Lifarizine [USAN:INN:BAN]
- UNII-C3705I245K
- Lyfarizine
- 1-(Diphenylmethyl)-4-((5-methyl-2-p-tolylimidazol-4-yl)methyl)piperazine
- RS 87476-000
- Piperazine, 1-(diphenylmethyl)-4-((5-methyl-2-(4-methylphenyl)-1H-imidazol-4-yl)methyl)-
Marca | Dados do produto | Pureza | Gama de preços | Estimativa de entrega |
---|---|---|---|---|
Lifarizine REF: TM-T27830CAS: 119514-66-8 | 99.12% | 141,00 €~1.477,00 € | Qui 13 Mar 25 |
Lifarizine
CAS:119514-66-8
Lifarizine (RS-87476), a calcium-sodium channel antagonist, shows neuroprotective activity in a simplified rat survival model …
Fórmula:
C29H32N4
Pureza:
99.12%
Cor e Forma:
Solid
Peso molecular:
436.59
Ref: TM-T27830
1mg | 141,00 € | ||
5mg | 326,00 € | ||
10mg | 495,00 € | ||
25mg | 798,00 € | ||
50mg | 1.096,00 € | ||
100mg | 1.477,00 € |
Entrega estimada em Estados Unidos, Quinta-feira 13 de Março de 2025